Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-04-17 09:35 am Purchase |
2025-03-31 | 13G | Vaxcyte, Inc. PCVX |
BLACKROCK INC BLK |
9,825,638 7.600% |
1,250,400 (+14.58%) |
Filing History |
| 2025-02-14 12:12 pm Sale |
2024-12-31 | 13G | Vaxcyte, Inc. PCVX |
JANUS HENDERSON GROUP PLC JHG |
10,575,363 8.500% |
-346,533 (-3.17%) |
Filing History |
| 2025-02-12 09:34 am Sale |
2024-12-31 | 13G | Vaxcyte, Inc. PCVX |
FMR CORP | 13,054,145 10.500% |
-2,692,522 (-17.10%) |
Filing History |
| 2024-11-14 5:46 pm Purchase |
2024-09-30 | 13G | Vaxcyte, Inc. PCVX |
RA Capital Management, L.P. | 12,649,728 9.990% |
2,964,649 (+30.61%) |
Filing History |
| 2024-11-14 2:53 pm Purchase |
2024-09-30 | 13G | Vaxcyte, Inc. PCVX |
JANUS HENDERSON GROUP PLC JHG |
10,921,896 9.800% |
3,940,520 (+56.44%) |
Filing History |
| 2024-11-12 10:34 am Purchase |
2024-11-08 | 13G | Vaxcyte, Inc. PCVX |
FMR CORP | 15,746,667 12.837% |
1,533,302 (+10.79%) |
Filing History |
| 2024-02-14 5:01 pm Purchase |
2023-12-31 | 13G | Vaxcyte, Inc. PCVX |
RA Capital Management, L.P. | 9,685,079 9.990% |
1,531,520 (+18.78%) |
Filing History |
| 2024-02-13 5:16 pm Purchase |
2023-12-29 | 13G | Vaxcyte, Inc. PCVX |
The Vanguard Group | 8,452,371 8.880% |
1,838,705 (+27.80%) |
Filing History |
| 2024-02-13 2:10 pm Purchase |
2023-12-31 | 13G | Vaxcyte, Inc. PCVX |
JANUS HENDERSON GROUP PLC JHG |
6,981,376 7.300% |
1,007,237 (+16.86%) |
Filing History |
| 2024-02-09 10:05 am Purchase |
2024-02-08 | 13G | Vaxcyte, Inc. PCVX |
FMR CORP | 14,213,365 14.937% |
4,044,084 (+39.77%) |
Filing History |
| 2024-01-25 1:48 pm Purchase |
2023-12-31 | 13G | Vaxcyte, Inc. PCVX |
BLACKROCK INC BLK |
8,575,238 9.000% |
3,469,868 (+67.97%) |
Filing History |
| 2023-02-14 4:45 pm Purchase |
2022-12-31 | 13G | Vaxcyte, Inc. PCVX |
RA Capital Management, L.P. | 8,153,559 9.990% |
4,287,751 (+110.91%) |
Filing History |
| 2023-02-10 4:29 pm Sale |
2022-12-31 | 13G | Vaxcyte, Inc. PCVX |
TPG GP A, LLC | 1,190,336 1.500% |
-2,959,208 (-71.31%) |
Filing History |
| 2023-02-10 4:14 pm Purchase |
2022-12-31 | 13G | Vaxcyte, Inc. PCVX |
Carlyle Group Inc. CG |
2,070,724 2.600% |
2,070,724 (New Position) |
Filing History |
| 2023-02-10 12:06 pm Purchase |
2022-12-31 | 13G | Vaxcyte, Inc. PCVX |
JANUS HENDERSON GROUP PLC JHG |
5,974,139 7.600% |
1,727,475 (+40.68%) |
Filing History |
| 2023-02-09 12:39 pm Purchase |
2023-02-09 | 13G | Vaxcyte, Inc. PCVX |
FMR CORP | 10,169,281 12.875% |
2,294,931 (+29.14%) |
Filing History |
| 2023-02-09 11:35 am Purchase |
2022-12-30 | 13G | Vaxcyte, Inc. PCVX |
The Vanguard Group | 6,613,666 8.370% |
3,479,380 (+111.01%) |
Filing History |
| 2023-02-03 12:10 pm Purchase |
2022-12-31 | 13G | Vaxcyte, Inc. PCVX |
BLACKROCK INC BLK |
5,105,370 6.500% |
2,316,363 (+83.05%) |
Filing History |
| 2022-03-09 5:18 pm Purchase |
2022-02-28 | 13G | Vaxcyte, Inc. PCVX |
BLACKROCK INC BLK |
2,789,007 5.000% |
11,960 (+0.43%) |
Filing History |
| 2022-02-14 6:44 pm Purchase |
2021-12-31 | 13G | Vaxcyte, Inc. PCVX |
Longitude Venture Partners II L.P. | 1,616,070 3.100% |
1,616,070 (New Position) |
Filing History |